Nektar is seeking collaborations in diabetes, infectious disease and oncology
Nektar business development
Nektar is a biopharmaceutical company with a different approach to medicine. They develop drugs that are easier to take, safer to use, longer lasting and more effective.
They look closely at existing therapies, and leverage their knowledge and extensive development expertise to evaluate how they can more effectively impact patients´ lives. They collaborate with partners who recognize the value they bring to product development. By sharing their assets and intellectual resources, they increase the therapeutic value of proven drugs and create new products that redefine what medicines are capable of doing.
Nektar collaborates with leading pharmaceutical and biotechnology companies to develop category-defining products with significant market impact. Their approach to these partnerships is solution-oriented and product-focused. They work to create and maintain open, responsive, and dynamic relationships based on a clear understanding of strategies and mutual goals.
Nektar's development programs focus on products that fill unmet needs in diabetes, infectious disease, oncology, and eventually other areas, where they can have significant impact.